课题基金 / 基金详情

IMMUNOGENETIC STUDIES IN CHILDHOOD AND ADOLESCENT MULTIPLE SCLEROSIS

IMMUNOGENETIC STUDIES IN CHILDHOOD AND ADOLESCENT MULTIPLE SCLEROSIS
儿童和青少年多发性硬化症的免疫遗传学研究
批准号:
7607897
负责人:
LAUREN B KRUPP
金额:
$0.07万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-23 至 2007-11-30

项目摘要

项目成果

LAUREN B KRUPP的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of this proposal is to identify the underlying genetic causes of MS. Specificaly, the current investigation seeks to assess genetic factors related to early-onset Multiple Sclerosis (MS). A vast body of previous research conclusively shows that there is a strong genetic influence on MS. Genes in their germline configuration influence susceptibility, disease progression and most likely, also response to treatment. Despite this evidence, it has been difficult to identify the specific genes involved. Previous work has looked at known genes thought to be candidates for having influence on MS - for example, genes that control immune system function and resistance to viral infection - but this approach has met with partial success. The technology now exists to identify the genes that cause MS susceptibility using unbiased and efficient methods. Identification of the exact molecular basis of MS susceptibility will undoubtedly result in new opportunities for treatment and/or prevention of this cruel disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MULTIPLE SCLERO
CLINICAL TRIAL: NEUROLOGIC AND NEUROCOGNITIVE FEATURES OF MULTIPLE SCLEROSIS IN
IMMUNOGENETIC STUDIES IN CHILDHOOD AND ADOLESCENT MULTIPLE SCLEROSIS
PROTEOMIC ANALYSIS OF PEDIATRIC MULTIPLE SCLEROSIS (MS), A PILOT STUDY
海外基金